Baxdrostat

Drug ingredient

CAS 1428652-17-8

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 1428652-17-8
US productionNot reported
Import value, 2024$907M
Top sourceIreland 47%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293379 · basket

These shares come from HS customs code 293379, which covers 105 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
IE 47%IrelandBE 19%BelgiumSG 11%SingaporeIT 4%ItalyCH 4%Switzerland
1 FDA-registered drug labeler
AstraZeneca AB

Why It Matters

Sectors
Health
Downstream UsesNot recorded
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS1428652-17-8
PubChem CID71535962
DTXSIDDTXSID701358954
FormulaC22H25N3O2
Mol. Weight363.5 g/mol
SMILESCCC(=O)NC1CCCC2=C1C=NC=C2C3=CC4=C(C=C3)N(C(=O)CC4)C

Data Sources

Brief citations

Baxdrostat (CAS 1428652-17-8) https://chemicalindependence.com/chemical/1428652-17-8/ PubChem: 71535962. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/71535962 FDA National Drug Code directory: CAS 1428652-17-8. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/ US Census international trade: HS 293379 for CAS 1428652-17-8. Reporting year: 2024. https://usatrade.census.gov/